Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Protecting early career physicians from commercial influence
The BMJ ( IF 93.6 ) Pub Date : 2024-09-09 , DOI: 10.1136/bmj.q1939
Alice Fabbri 1 , Quinn Grundy 2
The BMJ ( IF 93.6 ) Pub Date : 2024-09-09 , DOI: 10.1136/bmj.q1939
Alice Fabbri 1 , Quinn Grundy 2
Affiliation
Industry influence still threatens the integrity of healthcare and harms patients “To influence physicians from the bottom up” reads an internal company document published in the late 1990s from the drug manufacturer Parke-Davis.1 This memo, outlining the company’s business strategies for a section of its market, became public through litigation around off-label drug promotion. Among the company’s key promotional strategies was “to solidify Parke-Davis’s role in the resident’s mind as he/she evolves into a practising physician.”1 Over two decades later, drug and medical device industries globally continue to target clinicians early in their careers, including during periods of training, to cultivate long term, reciprocal relationships through payments, free meals, and sponsored education. Researchers recently examined payments to cardiology fellows in the United States before and after graduation, finding that 73% of cardiology fellows received payments in the year before graduation, jumping to 88% in the first few years after graduation.2 For fellows in specialties that use a lot of technology (referred to as “procedural intensive”), the proportion was even higher: …
中文翻译:
保护早期职业医生免受商业影响
行业影响力仍然威胁着医疗保健的诚信并伤害患者。药品制造商 Parke-Davis 在 20 世纪 90 年代末发布的一份公司内部文件中写道,“自下而上地影响医生”。1 这份备忘录概述了该公司一个部分的业务战略其市场份额通过围绕标签外药物促销的诉讼而公开。该公司的关键促销策略之一是“当住院医师逐渐成为执业医师时,巩固 Parke-Davis 在住院医生心目中的角色。”1 二十多年后,全球药品和医疗器械行业继续以处于职业生涯早期的临床医生为目标,包括在培训期间,通过付款、免费膳食和赞助教育来培养长期互惠关系。研究人员最近调查了美国心脏病学研究员毕业前后的付款情况,发现 73% 的心脏病学研究员在毕业前一年收到了付款,在毕业后的头几年跃升至 88%。2 对于使用很多技术(称为“程序密集型”),比例甚至更高:……
更新日期:2024-09-09
中文翻译:
保护早期职业医生免受商业影响
行业影响力仍然威胁着医疗保健的诚信并伤害患者。药品制造商 Parke-Davis 在 20 世纪 90 年代末发布的一份公司内部文件中写道,“自下而上地影响医生”。1 这份备忘录概述了该公司一个部分的业务战略其市场份额通过围绕标签外药物促销的诉讼而公开。该公司的关键促销策略之一是“当住院医师逐渐成为执业医师时,巩固 Parke-Davis 在住院医生心目中的角色。”1 二十多年后,全球药品和医疗器械行业继续以处于职业生涯早期的临床医生为目标,包括在培训期间,通过付款、免费膳食和赞助教育来培养长期互惠关系。研究人员最近调查了美国心脏病学研究员毕业前后的付款情况,发现 73% 的心脏病学研究员在毕业前一年收到了付款,在毕业后的头几年跃升至 88%。2 对于使用很多技术(称为“程序密集型”),比例甚至更高:……